Dr. Kunle Odunsi is the deputy director of the Roswell Park Cancer Institute, where he also serves as the chair of the Department of Gynecologic Oncology, the executive director of the Center for Immunotherapy, and the co-Leader of the Tumor Immunology and Immunotherapy research program. There, he oversees all scientific and clinical research-related initiatives, and works to transfer scientific discoveries into clinical settings.
Dr. Odunsi has made significant research contributions, which include the characterization of tumor antigens and then using them to develop immunotherapy vaccines for ovarian cancer patients. He has been elected as a Fellow of the National Academy of Medicine and is a fellow of both the Royal College of Obstetricians and Gynaecologists and the American College of Obstetricians and Gynecologists. In addition to being a member of CRI’s Scientific Advisory Council, Dr. Odunsi serves on the CLIP Grant Review Committee and is also a member of CRI’s Clinical Leadership Committee.
Clinical trials are no longer a shot in the dark. They are based on sound, scientific evidence that the treatment might lead to a cure.
Let's spread the word about Immunotherapy! Click to share this page with your community.